The U.S. legalizes psychedelic therapy nationwide, becoming the world’s largest country to do so
Psychedelic-assisted therapy could reach millions more Americans by 2033, when projected Medicaid expansion under a federal framework legalizing psilocybin, MDMA, and ketamine therapies takes hold. Clinical trials already show treatment-resistant depression patients achieving remission with psilocybin. If access gaps close, this law could quietly reshape how America treats its most stubborn mental health conditions.









